Cell line · CVCL_0290
HCC1937
Cancer cell line, Homo sapiens. Breast ductal carcinoma. 109 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Cite this record
ConductScience Library. HCC1937. Cell lines, record CVCL_0290. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0290
On this page
Cell line
As Cellosaurus gives it.
- Name
- HCC1937
- Accession
- CVCL_0290
- RRID
- RRID:CVCL_0290
- Synonyms
- Hcc1937, HCC-1937, HCC/1937, Hamon Cancer Center 1937
- Species
- Homo sapiens (Human)
- Sex
- Female
- Age at sampling
- 24Y
- Category
- Cancer cell line
- Diseases
- Breast ductal carcinoma (NCIt C4017)
- Derived from
- Breast (in situ)
- Entry created
- 2012-04-04
- Entry updated
- 2025-11-27
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers109
2 more articles give this line's RRID in its Methods without naming the line nearby, so they are not listed.
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Phosphoproteomic Profiling Identifies PAK4 S474 Phosphorylation Affects Docetaxel Chemosensitivity via Modulation of Microtubule Stabilization in Breast Cancer. | Biomedicines | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Inhibition of cyclin-dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation. | Mol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Cancer-Intrinsic Protein Neddylation Modulates the Intratumoral Immune Landscape to Constrain Immune Checkpoint Blockade Therapy. | Cancer Immunol Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Finding novel vulnerabilities of hypomorphic BRCA1 alleles. | Mol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Real-time cell viability monitoring for high-throughput drug screening using tumor xenograft-derived cells. | Cell Rep Methods | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Triple-Negative Breast Cancer Cells Utilize IL8 and CXCL1 to Suppress NK Cells' Function and Facilitate Cancer Metastasis. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Integrative Genomic Analysis Identifies MAGT1 as a Key Regulator of Proliferation and Poor Prognosis in Breast Cancer. | Hum Mutat | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Cancer genome standards for long-read sequencing using cancer cell line mixtures. | Gigascience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Detachment-Induced FAK-STAT3-NNMT Inhibits CTCs Anoikis to Promote Breast Cancer Metastasis by Enhancing Fatty Acid Oxidation. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Allogeneic Immune Cell Perfusion Inhibits the Growth of Vascularized 3D In Vitro Tumor Models, Induces Vascular Regression and Desmoplasia, but Promotes Tumor Cell Invasion. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 109
See all 109 papersRelatives5
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | EDITGENE BRCA1 Overexpression HCC1937 Stable Cell Line | CVCL_F6FU | Cell lines | |
| Derived from it | HCC1937 shPARG | CVCL_RA87 | Cell lines | |
| Derived from it | HCC1937/CMV-Luc | CVCL_4W92 | Cell lines | |
| Derived from it | HyCyte HCC1937 stable cell line for hBRCA1 overexpression | CVCL_F4NA | Cell lines | |
| From the same person | HCC1937 BL | CVCL_3281 | Cell lines |
Cell banks6
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0290
GET https://conductscience.org/api/cell-lines/v1/CVCL_0290/papers?page=2